New study identifies gut microbiome signature to predict Type 2 diabetes onset
A new study identified microbial signatures which predicted the onset of type 2 diabetes during nearly 16 years of follow-up in a large Finnish population cohort.
Diabetes, obesity, arthritis driving functional foot orthotics business upwards in the U.S.
The U.S. Government and military is also showing a heightened interest in functional foot orthotics for veterans, putting $60 million…
Obesity, diabetes and immune system: improving function during COVID for patients
Now is the time to strengthen immunity and improve overall wellness for patients in regard to obesity, diabetes and immune system health…
Berberine for weight loss, diabetes
Berberine for weight loss and diabetes can have multiple benefits as the American Diabetes Association (ADA) reports diabetes continues to rise…
3 ways to impact patients with type 2 diabetes
When it comes to your patients with Type 2 diabetes, you can have a big impact by discussing weight management, considering your own weight-management offerings and partnering with other professionals.
Gut microbiome may affect some anti-diabetes drugs
ccording to researchers at Wake Forest School of Medicine, bacteria that make up the gut microbiome may be the culprit. In a review of more than 100 current published studies in humans and rodents, the School of Medicine team examined how gut bacteria either enhanced or inhibited a drug’s effectiveness. The review is published in the Dec.11 edition of the journal EBioMedicine.
November is American Diabetes Month: Help your diabetic patients
Diabetes diagnoses increased more than 380 percent between 1988 and 2014, according to statistics compiled by the American Diabetes Association (ADA). This condition now afflicting more than 30 million adults and children in the U.S. alone. The ADA further states that this medical condition characterized by higher-than-normal blood sugar also takes the lives of more Americans per year than breast cancer and AIDS (acquired immunodeficiency syndrome) put together.
Can digestive enzymes benefit your patients with diabetes?
Your patients with diabetes know how serious this chronically debilitating disease can often be. However, if we look at the national statistics for both Type 1 and Type 2 diabetes, the stakes quickly escalate. The American Diabetes Association (ADA) estimated that more than 30 million Americans, or more than 9 percent of the population live with diabetes. Of those 30 million cases, almost 1.5 million will represent brand new cases of diabetes that are diagnosed for the first time in any given year.
Adding the management of diabetes and prediabetes to your practice
Feature You don’t have to choose to see people with diabetes in your practice; however, the prevalence of the disease among the population means you almost certainly already are. Now, an increasing number of practitioners are making the management of diabetes and prediabetes part of their practices. Their reasons for this are multiple. For one, their help is certainly needed. Nearly 1 in 3 Americans is diabetic or prediabetic, according to a recent Centers for Disease Control and Prevention report.
More than 100 Million Americans have diabetes or prediabetes
More than 100 million U.S. adults have diabetes or prediabetes, health officials say. As of 2015, more than 9 percent of the population—30.3 million—had diabetes. Another 84.1 million had prediabetes, the U.S. Centers for Disease Control and Prevention reported Tuesday. People with prediabetes have elevated blood sugar levels, but not so high that they have full-blown diabetes, which requires medication or insulin injections. With exercise and a healthy diet, prediabetics can halve their risk of developing type 2 diabetes.
